Recent Updates
Recently added Catalysts
JAZZ

Jazz Pharmaceuticals to Report 2019 Fourth Quarter and Full Year Financial Results on February 25, 2020 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2019 fourth quarter and full year financial results on Tuesday,...

Key Takeaway: DUBLIN , Feb. 11, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that it will report its 2019 fourth quarter and full year financial results on Tuesday, February 25, 2020 , after the close of the financial markets. Company management will host a liv

Full Press Release Details

DUBLIN , Feb. 11, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that it will report its 2019 fourth quarter and full year financial results on Tuesday, February 25, 2020 , after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST / 9:30 p.m. GMT to discuss fourth quarter and full year 2019 financial results and provide a business and financial update and guidance for 2020 financial results.
Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least one week.
Audio webcast/conference call: U.S. Dial-In Number: +1 855 353 7924 International Dial-In Number: +1 503 343 6056 Passcode: 9837779
A replay of the conference call will be available through March 3, 2020 and accessible through one of the following telephone numbers, using the passcode below:
Replay U.S. Dial-In Number: +1 855 859 2056 Replay International Dial-In Number: +1 404 537 3406 Passcode: 9837779
Jazz Pharmaceuticals Contacts:
Investors: Media:
Kathee Littrell Jacqueline Kirby
Vice President, Investor Relations Vice President, Corporate Affairs & Government Relations
Ireland, +353 1 634 7887 Ireland, +353 1 697 2141
U.S., +1 650 496 2717 U.S., +1 215 867 4910
SOURCE Jazz Pharmaceuticals plc

Related Links

21 %

Last updated: Feb 11, 2020